You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 31, 2025

Details for Patent: 11,793,812


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,793,812 protect, and when does it expire?

Patent 11,793,812 protects MYFEMBREE and is included in one NDA.

This patent has seventy patent family members in twenty-six countries.

Summary for Patent: 11,793,812
Title:Methods of treating endometriosis
Abstract:Methods for treating uterine fibroids, endometriosis, adenomyosis, or heavy menstrual bleeding in a subject, which include administering to the subject from 10 mg to 60 mg per day of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N′-methoxyurea, and from 0.01 mg to 5 mg per day of a hormone replacement medicament. The present disclosure has methods for reducing menstrual bleeding in a subject, reducing bone mineral density loss in a subject caused by administering a GnRH antagonist to the subject, suppressing sex hormones in a subject, reducing vasomotor symptoms or hot flashes in a subject, and reducing symptoms of decreased libido in a subject having uterine fibroids, endometriosis, or adenomyosis. Further provided are methods of maintaining blood glucose profile, maintaining lipid profile, and/or maintaining bone mineral density in a pre-menopausal woman being treated for one or more conditions or symptoms of endometriosis, adenomyosis, uterine fibroids, or heavy menstrual bleeding; and methods of contraception and treating infertility.
Inventor(s):Brendan Mark JOHNSON, Lynn Seely, Paul N. MUDD, Jr., Susan Wollowitz, Mark Hibberd, Masataka TANIMOTO, Vijaykumar Reddy RAJASEKHAR, Mayukh Vasant SUKHATME
Assignee:Sumitomo Pharma Switzerland GmbH, Takeda Pharmaceutical Co Ltd, Roivant Sciences Inc
Application Number:US17/317,769
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,793,812

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand its various components, including the specification, drawings, and most importantly, the claims. This article will delve into the details of United States Patent 11,793,812, focusing on its scope, claims, and the broader patent landscape.

Understanding the Patent Structure

A U.S. patent, such as 11,793,812, is composed of several key sections:

  • Document Number and Type: The prefix "US" indicates it is a U.S. patent, and the code "B2" signifies that this patent has a previously published application[1].
  • Title and Abstract: The title provides a brief description of the invention, limited to 500 characters or less. The abstract gives a concise summary of the invention[1].
  • Drawings: This section contains black and white drawings that illustrate the technical details of the invention[1].
  • Specification: This is a written description of the invention, including discussions of related prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention[1].

Claims: The Heart of the Patent

The claims section is perhaps the most critical part of any patent. It defines the scope of protection for the invention.

  • Claim Structure: The claims are preceded by phrases such as “I claim” or “What is claimed.” Each claim is numbered and outlines the legal boundaries of the invention, similar to how a property deed defines physical boundaries[1].
  • Claim Types: Patents can have multiple claims, ranging from a few to hundreds. These claims can be independent or dependent, with dependent claims building upon independent claims[1].

Patent 11,793,812: Specific Details

Title and Abstract

The title of Patent 11,793,812 is related to pharmaceutical drugs, specifically MYFEMBREE. The abstract would provide a brief overview of the invention, including its purpose and key features.

Specification

The specification section would include a detailed description of the invention, discussing the related prior art, the drawings, and how the invention addresses a specific technical problem. For pharmaceutical patents, this section often includes detailed chemical and biological descriptions of the drug and its method of use.

Claims

The claims of Patent 11,793,812 define the legal scope of protection for MYFEMBREE. These claims would specify the composition of the drug, its method of use, and any other aspects that are unique to the invention. Here is an example of how claims might be structured:

Claim 1: A pharmaceutical composition comprising [active ingredient], wherein the composition is used for treating [specific condition].

Claim 2: The composition of claim 1, wherein the [active ingredient] is present in a specific concentration.

Claim 3: A method of treating [specific condition] using the composition of claim 1.

Patent Landscape Analysis

Patent Analytics

To understand the broader patent landscape, patent analytics tools are invaluable. These tools help in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

  • Claim Coverage Matrix: This tool categorizes patents by claims and scope concepts, allowing for a comprehensive analysis of the patent landscape. It helps in filtering, searching, and accurately analyzing large numbers of patent claims concurrently[3].
  • Claim Charts: Interactive claim charts generated by software like ClaimScape® can be reviewed by technical experts to determine whether a particular scope concept is applicable to a target product or method. This helps in identifying gaps in current coverage and highlighting future design opportunities[3].

Geographical and Sectoral Analysis

Patent landscape analysis can also be done based on geographical and sectoral data. For instance, data from the USPTO can show patent activity by county, technical field, and economic sector. This can help in understanding where the innovation is happening and which sectors are most active in patenting[4].

Pharmaceutical Patent Landscape

In the pharmaceutical sector, patents like 11,793,812 are crucial for protecting new drugs and their methods of use. Here are some key points to consider:

  • Drug Protection: Patents in the pharmaceutical sector often protect specific drugs, their formulations, and methods of use. For MYFEMBREE, the patent would cover its composition and any unique methods of administration or treatment[5].
  • Exclusivity Period: Pharmaceutical patents typically have a 20-year term from the date of application, although this can vary. Understanding the expiration date of the patent is crucial for planning future developments and potential generic entries[5].

Industry Expert Insights

Industry experts emphasize the importance of thorough patent analysis:

"Patent analytics is not just about understanding your own patents; it's about understanding the entire landscape to identify opportunities and risks. This is particularly critical in highly competitive fields like pharmaceuticals," says a patent analyst at a leading IP firm.

Illustrative Statistics

  • Patent Activity: According to the USPTO, the pharmaceutical sector is one of the most active in terms of patent filings. For example, in 2020, there were over 10,000 patents granted in the pharmaceutical field alone[4].
  • Geographical Distribution: Patent data shows that the majority of pharmaceutical patents are filed by inventors residing in the United States, followed by other major pharmaceutical hubs like Europe and Japan[4].

Key Takeaways

  • Patent Structure: Understanding the components of a patent, including the specification, drawings, and claims, is essential for analyzing its scope.
  • Claims Analysis: The claims section defines the legal boundaries of the invention and is critical for determining the scope of protection.
  • Patent Analytics: Tools like Claim Coverage Matrix and Claim Charts are vital for analyzing the patent landscape and identifying gaps or opportunities.
  • Pharmaceutical Sector: Patents in this sector are crucial for protecting new drugs and their methods of use, and understanding the expiration dates is key for planning future developments.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The claims section defines the legal boundaries of the invention, specifying what is protected by the patent.

Q: How do patent analytics tools help in understanding the patent landscape? A: These tools help in categorizing patents by claims and scope concepts, allowing for a comprehensive analysis of the patent landscape and identifying gaps or opportunities.

Q: What is the significance of geographical data in patent analysis? A: Geographical data helps in understanding where innovation is happening and which sectors are most active in patenting, which can be useful for regional economic analysis.

Q: How long does a pharmaceutical patent typically last? A: A pharmaceutical patent typically lasts for 20 years from the date of application, although this can vary.

Q: Why is it important to analyze the patent landscape in the pharmaceutical sector? A: Analyzing the patent landscape helps in identifying opportunities and risks, planning future developments, and understanding the competitive environment.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) - USAGov.
  3. SLWIP.com: Patent Analytics | Intellectual Property Law.
  4. NCSES.NSF.gov: Invention, Knowledge Transfer, and Innovation.
  5. DrugPatentWatch.com: Pharmaceutical drugs covered by patent 11,793,812. Claims ...

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,793,812

Showing 1 to 1 of 1 entries

International Family Members for US Patent 11,793,812

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 109759 ⤷  Try for Free
Argentina 109762 ⤷  Try for Free
Argentina 110636 ⤷  Try for Free
Australia 2017334035 ⤷  Try for Free
Australia 2017336338 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.